一则临床进展公告拉动480亿港元市值!创新药“十倍股”药捷安康的“临床故事”,真有这么高含金量?

每日经济新闻
Sep 14

每经记者:金喆每经编辑:董兴生9月12日,药捷安康-B(02617.HK)用最高超130%、单日上涨77.09%的涨幅,诠释了当下港股创新药板块的疯狂。截至当日收盘,药捷安康总市值达到764亿港元,排在港股创新药板块第12位。药捷安康也是今年港股创新药概念股中唯一的“十倍股”,6月23日挂牌上市以来,在不到3个月时间里股价涨幅达到1363.88%。药捷安康作为一家2014年成立的创新药企,主要从事...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10